日本莫亚莫亚病的发病率,流行率和治疗:基于人口的描述性研究
Hao Liu1, Toshiki Fukasawa2, Takayuki Anno1
1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
概括
自2003年以来,日本的莫亚莫亚病 (MMD) 发病率和流行率有所增加. 这项研究更新了对MMD患者的重血管化和抗血小板治疗趋势的估计和分析.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 莫亚莫亚病 (MMD) 涉及内动脉的渐进性狭窄.
- 之前的日本调查显示,MMD发病率和流行率呈上升趋势.
- 需要更新MMD的流行病学数据和治疗趋势.
研究的目的:
- 为日本提供MMD发病率和流行率的最新估计.
- 分析MMD患者的重血管化程序的趋势.
- 评估抗血小板治疗在MMD患者群体中的使用情况.
主要方法:
- 基于日本索赔数据库的基于人口的描述性研究.
- 2015年日本人口普查 (财政年度2015-2019) 的标准化发病率和流行率估计.
- 计算出重血管化和抗血小板治疗使用的1年累积发病率.
主要成果:
- 每10万人口中的MMD发病率从1.8增加到2.4.
- 每10万人口中的MMD患病率从14.7上升到17.6.
- 一年复血管化发生率在21.9%至28.9%之间;抗血小板治疗使用率在36.6%至39.0%之间.
结论:
- 日本的MMD发病率和流行率 (2015-2019财年) 比以前报告的要高.
- 观察到的重血管化和抗血小板治疗的趋势可以为临床实践的改进提供信息.
- 这项研究为莫亚莫亚病管理提供了关键的流行病学更新.
更多相关视频
相关概念视频
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Regulation of Stroke Volume
3.2K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.2K


